ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442
   PubMed Web of Science ®Google Scholar
• Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer. 2009;9(9):631–643. doi:10.1038/nrc2713
   PubMed Web of Science ®Google Scholar
• Chia S, Bryce C, Gelmon K. The 2000 EBCTCG overview: a widening gap. Lancet. 2005;365(9472):1665–1666. doi:10.1016/S0140-6736(05)66524-5
   PubMed Web of Science ®Google Scholar
• Fisher B, Redmond C, Brown A, et al. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol. 1983;1(4):227–241. doi:10.1200/JCO.1983.1.4.227
   PubMed Web of Science ®Google Scholar
• Yang G, Nowsheen S, Aziz K, Georgakilas AG. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs. Pharmacol Ther. 2013;139(3):392–404. doi:10.1016/j.pharmthera.2013.05.005
   PubMed Web of Science ®Google Scholar
• Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol. 1998;45(6):608–612. doi:10.1046/j.1365-2125.1998.00733.x
   PubMed Web of Science ®Google Scholar
• Peters-Engl C, Frank W, Danmayr E, Friedl HP, Leodolter S, Medl M. Association between endometrial cancer and tamoxifen treatment of breast cancer. Breast Cancer Res Treat. 1999;54(3):255–260. doi:10.1023/A:1006126411210
   PubMed Web of Science ®Google Scholar
• Petinari L, Kohn LK, de Carvalho JE, Genari SC. Cytotoxicity of tamoxifen in normal and tumoral cell lines and its ability to induce cellular transformation in vitro. Cell Biol Int. 2004;28(7):531–539. doi:10.1016/j.cellbi.2004.04.008
   PubMed Web of Science ®Google Scholar
• Chen HY, Yang YM, Han R, Noble M. MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. J Neurosci. 2013;33(38):15069–15074. doi:10.1523/JNEUROSCI.2729-13.2013
   PubMed Web of Science ®Google Scholar
• Nass N, Kalinski T. Tamoxifen resistance: from cell culture experiments towards novel biomarkers. Pathol Res Pract. 2015;211(3):189–197. doi:10.1016/j.prp.2015.01.004
   PubMed Web of Science ®Google Scholar
• Zhang T, Wan Y, Xie H, et al. Degradation chemistry and stabilization of exfoliated few-layer black phosphorus in water. J Am Chem Soc. 2018;140(24):7561–7567. doi:10.1021/jacs.8b02156
   PubMed Web of Science ®Google Scholar
• Zhou W, Pan T, Cui H, Zhao Z, Chu PK, Yu XF. Black phosphorus: bioactive nanomaterials with inherent and selective chemotherapeutic effects. Angew Chem Int Ed Engl. 2019;58(3):769–774. doi:10.1002/anie.201810878
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603–1616. doi:10.1016/j.freeradbiomed.2010.09.006
   PubMed Web of Science ®Google Scholar
• Martin C, Schulz R, Rose J, Heusch G. Inorganic phosphate content and free energy change of ATP hydrolysis in regional short-term hibernating myocardium. Cardiovasc Res. 1998;39(2):318–326. doi:10.1016/S0008-6363(98)00086-8
   PubMed Web of Science ®Google Scholar
• Di Marco GS, Hausberg M, Hillebrand U, et al. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. Am J Physiol Renal Physiol. 2008;294(6):F1381–7. doi:10.1152/ajprenal.00003.2008
   PubMed Web of Science ®Google Scholar
• Spina A, Sapio L, Esposito A, Di Maiolo F, Sorvillo L, Naviglio S. Inorganic phosphate as a novel signaling molecule with antiproliferative action in MDA-MB-231 breast cancer cells. Biores Open Access. 2013;2(1):47–54. doi:10.1089/biores.2012.0266
   PubMedGoogle Scholar
• Wang H, Yang X, Shao W, et al. Ultrathin black phosphorus nanosheets for efficient singlet oxygen generation. J Am Chem Soc. 2015;137(35):11376–11382. doi:10.1021/jacs.5b06025
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang T, Fan F, Gao F, Ji H, Yang L. Piezoelectric materials as sonodynamic sensitizers to safely ablate tumors: a case study using black phosphorus. J Phys Chem Lett. 2020;11(4):1228–1238. doi:10.1021/acs.jpclett.9b03769
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang W, Cui Y, Zhou N, Shen J. Near-infrared light-mediated photodynamic/photothermal therapy nanoplatform by the assembly of Fe(3)O(4) carbon dots with graphitic black phosphorus quantum dots. Int J Nanomedicine. 2018;13:2803–2819. doi:10.2147/IJN.S156434
   PubMed Web of Science ®Google Scholar
• Qin H, Chen J, Li Y, Gao L, Sun Z. Inflammatory response induced by black phosphorus nanosheets in mice and macrophages. Sci Total Environ. 2021;146860. doi:10.1016/j.scitotenv.2021.146860
   Web of Science ®Google Scholar
• Su Z, Xiao Z, Huang J, et al. Dual-Sensitive PEG-sheddable nanodrug hierarchically incorporating PD-L1 antibody and zinc phthalocyanine for improved immuno-photodynamic therapy. ACS Appl Mater Interfaces. 2021;13(11):12845–12856. doi:10.1021/acsami.0c20422
   PubMed Web of Science ®Google Scholar
• Huang J, Xiao Z, An Y, et al. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy. Biomaterials. 2021;269:120636. doi:10.1016/j.biomaterials.2020.120636
   PubMed Web of Science ®Google Scholar
• Huang J, Zheng C, Xiao H, et al. A polymer‑calcium phosphate nanocapsule for RNAi-induced oxidative stress and cascaded chemotherapy. J Control Release. 2021;340:259–270. doi:10.1016/j.jconrel.2021.10.030
   PubMed Web of Science ®Google Scholar
• Yuan Y, Wang Y, Huang H, Tao S, Huang J. Fine-tuned polymer nanoassembly for codelivery of chemotherapeutic drug and siRNA. Macromol Biosci. 2023;23:e2200529. doi:10.1002/mabi.202200529
   PubMed Web of Science ®Google Scholar
• Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat. 2014;17(4–6):89–95. doi:10.1016/j.drup.2014.10.002
   PubMed Web of Science ®Google Scholar
• Qiu S, Zhou Y, Zhou X, et al. Air-stable polyphosphazene-functionalized few-layer black phosphorene for flame retardancy of epoxy resins. Small. 2019;15(10):e1805175. doi:10.1002/smll.201805175
   PubMed Web of Science ®Google Scholar
• Peng L, Mei X, He J, et al. Monolayer nanosheets with an extremely high drug loading toward controlled delivery and cancer theranostics. Adv Mater. 2018;30(16):e1707389. doi:10.1002/adma.201707389
   PubMed Web of Science ®Google Scholar
• Gabellone S, Piccinino D, Filippi S, et al. Lignin nanoparticles deliver novel thymine biomimetic photo-adducts with antimelanoma activity. Int J Mol Sci. 2022;23(2):915. doi:10.3390/ijms23020915
   PubMed Web of Science ®Google Scholar
• Zhou W, Cui H, Ying L, Yu XF. Enhanced cytosolic delivery and release of CRISPR/Cas9 by black phosphorus nanosheets for genome editing. Angew Chem Int Ed Engl. 2018;57(32):10268–10272. doi:10.1002/anie.201806941
   PubMed Web of Science ®Google Scholar
• Planas O, Macia N, Agut M, Nonell S, Heyne B. Distance-dependent plasmon-enhanced singlet oxygen production and emission for bacterial inactivation. J Am Chem Soc. 2016;138(8):2762–2768. doi:10.1021/jacs.5b12704
   PubMed Web of Science ®Google Scholar
• Ishibashi KI, Fujishima A, Watanabe T, Hashimoto K. Detection of active oxidative species in TiO2 photocatalysis using the fluorescence technique. Electrochem commun. 2000;2(3):207–210. doi:10.1016/S1388-2481(00)00006-0
   Web of Science ®Google Scholar
• Altmeyer C, Karam TK, Khalil NM, Mainardes RM. Tamoxifen-loaded poly(L-lactide) nanoparticles: development, characterization and in vitro evaluation of cytotoxicity. Mater Sci Eng C Mater Biol Appl. 2016;60:135–142. doi:10.1016/j.msec.2015.11.019
   PubMed Web of Science ®Google Scholar
• Zhang X, Xie H, Liu Z, et al. Black phosphorus quantum dots. Angew Chem Int Ed Engl. 2015;54(12):3653–3657. doi:10.1002/anie.201409400
   PubMed Web of Science ®Google Scholar
• Liu F, Lin L, Zhang Y, et al. Two-dimensional nanosheets with high curcumin loading content for multimodal imaging-guided combined chemo-photothermal therapy. Biomaterials. 2019;223:119470. doi:10.1016/j.biomaterials.2019.119470
   PubMed Web of Science ®Google Scholar
• Miyaji A, Kohno M, Inoue Y, Baba T. Hydroxyl radical generation by dissociation of water molecules during 1.65 MHz frequency ultrasound irradiation under aerobic conditions. Biochem Biophys Res Commun. 2017;483(1):178–182. doi:10.1016/j.bbrc.2016.12.171
   PubMed Web of Science ®Google Scholar
• Milne L, Stewart I, Bremner DH. Comparison of hydroxyl radical formation in aqueous solutions at different ultrasound frequencies and powers using the salicylic acid dosimeter. Ultrason Sonochem. 2013;20(3):984–989. doi:10.1016/j.ultsonch.2012.10.020
   PubMed Web of Science ®Google Scholar
• Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. P T. 2017;42(12):742–755. doi:10.1155/2015/123756
   PubMedGoogle Scholar
• Zhang GJ, Kimijima I, Onda M, et al. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. Clin Cancer Res. 1999;5(10):2971–2977.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Zhou H, et al. Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer. Cell Death Dis. 2021;12(11):1000. doi:10.1038/s41419-021-04288-1
   PubMed Web of Science ®Google Scholar
• Cuzick J, Forbes JF, Sestak I, et al. International breast cancer intervention study, long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst. 2007;99(4):272–282. doi:10.1093/jnci/djk049
   PubMed Web of Science ®Google Scholar
• Fontana G, Maniscalco L, Schillaci D, Cavallaro G, Giammona G. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv. 2005;12(6):385–392. doi:10.1080/10717540590968855
   PubMed Web of Science ®Google Scholar
• Shete H, Chatterjee S, De A, Patravale V. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. Int J Pharm. 2013;454(1):584–592. doi:10.1016/j.ijpharm.2013.03.036
   PubMed Web of Science ®Google Scholar
• Davies C, Godwin J, Gray R, et al.; G. Early Breast Cancer Trialists’ Collaborative. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–784.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Stewart J, Allen C, Jaffray DA. Intracellular uptake, transport, and processing of nanostructures in cancer cells. Nanomedicine. 2009;5(2):118–127. doi:10.1016/j.nano.2009.01.008
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil(R)--The first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–134. doi:10.1016/j.jconrel.2012.03.020
   PubMed Web of Science ®Google Scholar
• Sharma A, Jain N, Sareen R. Nanocarriers for diagnosis and targeting of breast cancer. Biomed Res Int. 2013;2013:960821. doi:10.1155/2013/960821
   PubMed Web of Science ®Google Scholar
• Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci. 2004;7(2):252–259.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Li BA, Li ZY, Xia N, Yu HY, Zhang YZ. Synthesis and characterization of Tamoxifen citrate modified reduced graphene oxide nano sheets for breast cancer therapy. J Photochem Photobiol B. 2018;180:68–71. doi:10.1016/j.jphotobiol.2017.12.017
   PubMed Web of Science ®Google Scholar
• Maji R, Dey NS, Satapathy BS, Mukherjee B, Mondal S. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. Int J Nanomedicine. 2014;9:3107–3118. doi:10.2147/IJN.S63535
   PubMed Web of Science ®Google Scholar
• Sandhu PS, Kumar R, Beg S, et al. Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin: systematic approach for improved breast cancer therapeutics. Nanomedicine. 2017;13(5):1703–1713. doi:10.1016/j.nano.2017.03.003
   PubMed Web of Science ®Google Scholar
• How CW, Rasedee A, Manickam S, Rosli R. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity. Colloids Surf B Biointerfaces. 2013;112:393–399. doi:10.1016/j.colsurfb.2013.08.009
   PubMed Web of Science ®Google Scholar
• Guney Eskiler G, Cecener G, Dikmen G, Egeli U, Tunca B. Solid lipid nanoparticles: reversal of tamoxifen resistance in breast cancer. Eur J Pharm Sci. 2018;120:73–88. doi:10.1016/j.ejps.2018.04.040
   PubMed Web of Science ®Google Scholar
• Caster JM, Patel AN, Zhang T, Wang A. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(1). doi:10.1002/wnan.1416
   PubMed Web of Science ®Google Scholar
• Day CM, Hickey SM, Song Y, Plush SE, Garg S. Novel tamoxifen nanoformulations for improving breast cancer treatment: old wine in new bottles. Molecules. 2020;25(5). doi:10.3390/molecules25051182
   Web of Science ®Google Scholar
• Dalvai M, Bystricky K. Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and ER target gene expression. PLoS One. 2010;5(6):e11011. doi:10.1371/journal.pone.0011011
   PubMed Web of Science ®Google Scholar
• Li Z, Cui J, Yu Q, Wu X, Pan A, Li L. Evaluation of CCND1 amplification and CyclinD1 expression: diffuse and strong staining of CyclinD1 could have same predictive roles as CCND1 amplification in ER positive breast cancers. Am J Transl Res. 2016;8(1):142–153.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, O’Grady S, Tang M, Crown J. MYC as a target for cancer treatment. Cancer Treat Rev. 2021;94:102154. doi:10.1016/j.ctrv.2021.102154
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714–726. doi:10.1038/nrc3599
   PubMed Web of Science ®Google Scholar
• Li WH, Wu JJ, Wu L, et al. Black phosphorous nanosheet: a novel immune-potentiating nanoadjuvant for near-infrared-improved immunotherapy. Biomaterials. 2021;273:120788. doi:10.1016/j.biomaterials.2021.120788
   PubMed Web of Science ®Google Scholar
• Nguyen HT, Byeon JH, Phung CD, et al. Method for the instant in-flight manufacture of black phosphorus to assemble core@shell nanocomposites for targeted photoimmunotherapy. ACS Appl Mater Interfaces. 2019;11(28):24959–24970. doi:10.1021/acsami.9b04632
   PubMed Web of Science ®Google Scholar
• Liang X, Ye X, Wang C, et al. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release. 2019;296:150–161. doi:10.1016/j.jconrel.2019.01.027
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang J, Li C, Lu Y, Cheng L, Liu J. A targeting black phosphorus nanoparticle based immune cells nano-regulator for photodynamic/photothermal and photo-immunotherapy. Bioact Mater. 2021;6(2):472–489. doi:10.1016/j.bioactmat.2020.08.024
   PubMed Web of Science ®Google Scholar